-
Mashup Score: 0FDA Accepts BLA for Merck’s Pneumococcal Vaccine - 5 month(s) ago
The company’s investigational V116 vaccine covers 21 serotypes, and if approved, it would be the first pneumococcal conjugate vaccine specifically designed for adults.
Source: www.contagionlive.comCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 0FDA Approves Letermovir (Prevymis) for Preventing CMV in Adult Kidney Transplant Patients - 11 month(s) ago
The federal agency gave Merck the nod to use the company’s antiviral as prophylaxis for Cytomegalovirus Disease (CMV), postoperatively.
Source: ContagionLiveCategories: Infectious Disease, Latest HeadlinesTweet
-
Mashup Score: 0Merck Files Suit Against Federal Government Over Drug Pricing Program - 11 month(s) ago
The federal lawsuit filed in court looks to stop the government’s plan to negotiate therapy prices.
Source: ContagionLiveCategories: Infectious Disease, Latest HeadlinesTweet
-
Mashup Score: 0சிறுநீர்ப்பை புற்றுநோயின் அறிகுறிகள் என்ன? | Checkup | DR Anitha Ramesh Interview | Bladder cancer - 11 month(s) ago
சிறுநீர்ப்பை புற்றுநோயின் அறிகுறிகள் என்ன? | Checkup | DR Anitha Ramesh Interview!#bladdercancer #doctor #interview கலைஞர் செய்திகள் தொலைக்காட்சி இப்போது அனை…
Source: YouTubeCategories: Hem/Oncs, Latest HeadlinesTweet-
#Treatment : Surgery, radiation therapy, chemotherapy, #Immunotherapy #Avelumab #urinarybladdercancer #merck Symptoms: Blood in the urine, pain with urination . https://t.co/0W7Vd3RrVI #KalaignarSeithigal #tvshow show https://t.co/4mMmmCONf8
-
-
Mashup Score: 1Merck Files Suit Against Federal Government Over Drug Pricing Program - 11 month(s) ago
The federal lawsuit filed in court looks to stop the government’s plan to negotiate therapy prices.
Source: ContagionLiveCategories: Infectious Disease, Latest HeadlinesTweet
-
Mashup Score: 1Merck Sues Over Law Empowering Medicare to Negotiate With Drugmakers - 11 month(s) ago
The company is heavily reliant on a cancer drug that could be targeted by a program intended to lower drug prices.
Source: www.nytimes.comCategories: Latest Headlines, Oncologists2Tweet
-
Mashup Score: 3FDA Approves Letermovir (Prevymis) for Preventing CMV in Adult Kidney Transplant Patients - 11 month(s) ago
The federal agency gave Merck the nod to use the company’s antiviral as prophylaxis for Cytomegalovirus Disease (CMV), postoperatively.
Source: ContagionLiveCategories: Infectious Disease, Latest HeadlinesTweet
-
Mashup Score: 2Merck, Moderna detail potential skin cancer vaccine progress - 1 year(s) ago
Shares of Merck and Moderna jumped Tuesday after the drugmakers said a potential skin cancer vaccine they are developing using the same technology behind COVID-19 preventive shots fared well in a small study.
Source: medicalxpress.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 5
The regulator chided Merck for a “lack of transparency” and “conduct contrary to merit-based competition.”
Source: STATCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 2
Merck on Wednesday agreed to extend an ongoing collaboration with Moderna to develop a personalized vaccine for the treatment of patients with skin cancer.
Source: STATCategories: General Medicine News, Latest HeadlinesTweet
The company’s investigational V116 vaccine covers 21 serotypes, and if approved, it would be the first pneumococcal conjugate vaccine specifically designed for adults. #Merck https://t.co/nS2ryjNVKJ